US20050153993A1 - Treatment of statin side effects using uridine derivatives - Google Patents

Treatment of statin side effects using uridine derivatives Download PDF

Info

Publication number
US20050153993A1
US20050153993A1 US10/499,078 US49907805A US2005153993A1 US 20050153993 A1 US20050153993 A1 US 20050153993A1 US 49907805 A US49907805 A US 49907805A US 2005153993 A1 US2005153993 A1 US 2005153993A1
Authority
US
United States
Prior art keywords
uridine
statin
salt
treatment
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/499,078
Inventor
Anthony Linnane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Magral Pty Ltd
Original Assignee
Magral Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AUPR9511A priority Critical patent/AUPR951101A0/en
Priority to AUPR9511 priority
Application filed by Magral Pty Ltd filed Critical Magral Pty Ltd
Priority to PCT/AU2002/001685 priority patent/WO2003049730A1/en
Assigned to CENTRE FOR MOLECULAR BIOLOGY AND MEDICINE reassignment CENTRE FOR MOLECULAR BIOLOGY AND MEDICINE ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LINNANE, ANTHONY W.
Assigned to MAGRAL PTY LTD. reassignment MAGRAL PTY LTD. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: CENTRE FOR MOLECULAR BIOLOGY AND MEDICINE
Publication of US20050153993A1 publication Critical patent/US20050153993A1/en
Abandoned legal-status Critical Current

Links